The Greenwall Foundation will host a live webcast panel, “Restoring Trust in the FDA,” on Thursday, September 29, 2022, at 12:30pm EDT. The webcast is open to the public. Registration is required.
Award-winning journalist Adam Feuerstein, senior writer for STAT News, will join members of the Greenwall Faculty Scholars community in a discussion on the evolving nature of trust in our public health institutions. The panel will delve into recent issues and controversies surrounding the FDA, such as the agency’s approval of the Alzheimer’s drug Aduhelm, the role of advisory committees, tobacco regulation, COVID-19 vaccine approvals, and more. This discussion will also explore what is needed to restore trust in the FDA.
In addition to moderating the panel discussion, Feuerstein will discuss the role of media in supporting – or questioning – trust in our institutions, and how he and his STAT colleagues garnered a 2021 George Polk Award for their coverage of the FDA’s controversial review and approval of the Alzheimer’s treatment Aduhelm.
Participating in the panel are leading bioethics scholars who have been front and center on issues involving the FDA: Jason Karlawish, MD, Professor of Medicine, Medical Ethics and Health Policy, and Neurology at the University of Pennsylvania; Aaron Kesselheim, MD, JD, Professor of Medicine at Harvard Medical School; Holly Fernandez Lynch, JD, Assistant Professor of Medical Ethics at the University of Pennsylvania; and Keith Wailoo, PhD, Henry Putnam University Professor of History and Public Affairs at Princeton University.
“Bioethics has a central role to play in understanding and strengthening trust. Bringing together STAT’s savvy reporting and the ethics and policy expertise of our Scholars community, we hope to generate ideas for potential solutions to rebuild trust where it has been weakened or lost,” said Michelle Groman, JD, President & CEO of The Greenwall Foundation.
“Restoring Trust in the FDA” is a special event presented by The Greenwall Foundation to mark the twentieth anniversary of its flagship Faculty Scholars Program, which boasts over 60 Scholars from more than 40 different institutions, each with a distinct perspective and focus. Over the last two decades, the Faculty Scholars Program has helped to build the next generation of leaders in bioethics by supporting early-career faculty members to carry out innovative bioethics research, and by building an intellectually rich and active community.